NCT05351684View on ClinicalTrials.gov

Effect of Dolutegravir Intensification on HIV-1 Reservoirs

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

August 28, 2022

Study Completion Date

December 13, 2022

Conditions
HIV-1-infection
Interventions
DRUG

Dolutegravir 50 MG

already included in arm/group descriptions.

Trial Locations (1)

4000

Liège university hospital, Liège

All Listed Sponsors
lead

University of Liege

OTHER

NCT05351684 - Effect of Dolutegravir Intensification on HIV-1 Reservoirs | Biotech Hunter | Biotech Hunter